E-Cadherin Expression in Surgically-Resected Non-Small Cell Lung Cancers - A Clinicopathological Study

Background: E-Cadherin is a subclass of the cadherin family that plays a major role in the maintenance of intercellular junctions in normal epithelium. Decreased expression of E-cadherin might be closely related to invasiveness and dedifferentiation in human cancers. This study is aimed at investigating the clinicopathological significance of E-cadherin expression and its impact on the prognosis in surgically resected non-small-cell lung cancer patients. Methods: Using immunohistochemical staining, the expression of E-cadherin was studied in 207 surgically resected lung cancer specimens from January 1990 through December 1994. The clinicopathological data and survival status were recorded and analysed against the E-cadherin expression level in each tumor. Results: E-cadherin expression was detected in 122 of the 207 lung tumors (59.0 %), and the expression was significantly lower in tumors with poor differentiation (p < 0.001), in tumors with vascular invasion (p < 0.05), and in tumors with direct invasion into surrounding structures (p < 0.01). There was no correlation between E-cadherin expression, and tumor stage and regional lymph-node metastasis.There was no significant difference in survival rate between higher (> 40 %) and lower (< 40 %) E-cadherin expression groups; however, in tumors 3 cm or less, a significant difference was found between higher and lower E-cadherin expressions (p < 0.0001). Conclusions: Underexpression of E-cadherin is associated with poor differentiation and invasiveness in NSCLC. In patients with small NSCLC (≤ 3 cm), higher E-cadherin expression (> 40 %) significantly had a favorable prognosis.

Key words:

E-cadherinLung cancer

References

• 1 Yoshida-Noro C, Suzuki N, Takeichi T M. Molecular nature of the calcium-dependent cell-cell adhesion system in mouse teratocarcinoma and embryonic cells studied with a monoclonal antibody.  Dev Biol. 1984;  101 19-27
• 2 Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator.  Science. 1991;  251 1451-1455
• 3 Shimoyama Y, Hirohashi S, Hirano S. et al . Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas.  Cancer Res. 1989;  49 2128-2133
• 4 Frixen U H, Behrens J, Sachs M. et al . E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.  J Cell Biol. 1991;  113 173-185
• 5 Schipper J H, Frixen U H, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.  Cancer Res. 1991;  51 6328-6337
• 6 Brabant G, Hoang-Vu C, Cetin Y. et al . E-cadherin: a differentiation marker in thyroid malignancies.  Cancer Res. 1993;  53 4987-4993
• 7 Oka H, Shiozaki H, Kobayashi K. et al . Expression of E-cadherin cell adhesion molecules in human breast cancer tissue and its relationship to metastasis.  Cancer Res. 1993;  53 1696-1701
• 8 Böhm M, Totzeck B, Wieland I. Differences of E-cadherin expression levels and patterns in human lung cancer.  Ann Hematol. 1994;  68 81-83
• 9 Oka H, Shiozaki H, Kobayashi K. et al . Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer.  Virchows Archiv A Pathol Anat. 1992;  421 149-156
• 10 Bongiorno P F, Al-Kasspooles M, Lee S W. et al . E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus.  B J Cancer. 1995;  71 166-172
• 11 Shibanuma H, Hirano T, Tsuhi K. et al . Influence of E-cadherin dysfunction upon local invasion and metastasis in non-small cell lung cancer.  Lung Cancer. 1998;  22 85-95
• 12 Sulzer M A, Leers M P, Van Noord J A, Bollen E C, Theunissen P H. Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer.  Am J Respir Crit Care Med. 1998;  157 1319-1323
• 13 Smythe W R, Williams J P, Wheelock M J, Johnson K R, Kaiser L R, Albelda S M. Cadherin and catenin expression in normal human bronchial epithelium and non-small cell lung cancer.  Lung cancer. 1999;  24 157-168
• 14 Lee Y C, Chang Y-L, Luh S P, Lee J M, Chen J S. Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancer.  Ann Thorac Surg. 1999;  68 343-348
• 15 Doki Y, Shiozaki H, Tahara H. et al . Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line.  Cancer Res. 1993;  53 3421-3426
• 16 Shimoyama Y, Nagafuchi A, Fujita S. et al . Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness.  Cancer Res. 1992;  52 5770-5774
• 17 Retera J M, Leers M P, Sulzer M A, Theunissen P H. The expression of beta-catenin in non-small cell lung cancer: a clinicopathological study.  J Clin Pathol. 1998;  51 891-894
• 18 Mattussen V, Peters H M, Schalkwijk L. et al . E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome.  Int J Cancer. 1993;  55 580-585